Brief: Advicenne Receives Health Canada Clearance To Extend Its Pivotal Phase III Trial Of Adv7103 In Canada

Advicenne SA

15/10/2018 17:28

Oct 15 (Reuters) - ADVICENNE SA  ADVIC.PA :
    * ADVICENNE RECEIVES HEALTH CANADA CLEARANCE TO EXTEND ITS PIVOTAL PHASE III TRIAL OF
ADV7103 IN
CANADA
    * RECEIVED A NO OBJECTION LETTER TO EXTEND ITS ARENA-2 PIVOTAL PHASE III TRIAL FOR TREATMENT
OF
DISTAL RENAL TUBULAR ACIDOSIS (DRTA) IN CANADA

Source text for Eikon:  ID:nBw3yTFFDa 
Further company coverage:  ADVIC.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))